ROBERT GEORGE: Open Payments
NPI 1346754116 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,894 in 125 payments from 31 companies in 2025. Trend: 2023 $2,560 · 2024 $1,781 · 2025 $1,894
Food & beverage: $1,894
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $340 |
| Novo Nordisk Inc | 16 | $262 |
| PFIZER INC. | 13 | $166 |
| Eisai Inc. | 7 | $155 |
| Lilly USA, LLC | 8 | $111 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $107 |
| Verona Pharma, Inc. | 4 | $80 |
| GlaxoSmithKline, LLC. | 5 | $73 |
| Phathom Pharmaceuticals, Inc. | 4 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $48 |
Products named: QULIPTA, Leqembi, NURTEC ODT, Wegovy, Ozempic, UBRELVY, CAPLYTA, REXULTI.
Industry payments across NC — which companies pay providers there.
